# Rupatadine in Patients With Ulcerative Colitis

> **NCT07064707** · PHASE2 · RECRUITING · sponsor: **Alexandria University** · enrollment: 60 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Mesalamine
- **DRUG:** Rupatadine

## Key facts

- **NCT ID:** NCT07064707
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2026-07-15
- **Final completion:** 2026-10-21
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07064707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07064707, "Rupatadine in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07064707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*